Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study.
By H. Feldman, C. Johannes, Carol A. Derby, K. Kleinman, Beth A. Mohr, A. Araujo, J. Mckinlay. Preventive Medicine, 2000
754 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health, Toxicology
View Paper: https://www.semanticscholar.org/paper/4fbf569b2ceb25b91505fe5d9c8910f2a327f67c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Psychiatry and Mental health
Citations in the corpus
- European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, positive): “ED is a marker for CVD and a predictor of future events in middle-aged and older men but not beyond that offered by the Framingham risk score.(182) – 184 Lifestyle modification and pharmacotherapy for risk factors are effective in improving sexual function in men with ED.”
- Androgens and cardiovascular disease. (2003, positive): “This suggests the following: 1) ED may be a sentinel feature of atherosclerosis with prognostic significance for men’s general health (391), and 2) primary prevention may retard progression of ED (392).”